dr. zujewski on the length of time for an oncology drug to be approved by the fda
Published 11 years ago • 25 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
14:59
fresco2 study: fda approval of fruquintinib for refractory colorectal cancer
-
53:28
fda approval considerations with dr. paul kluetz
-
15:00
new fda-approved targeted drug for treatment-resistant, er positive her2 negative breast cancer
-
15:53
ev-103 study by dr. jonathan rosenberg led to the fda approval of enfortumab pembrolizumab
-
3:48
fda oncology center of excellence’s project facilitate
-
1:52
fda approves atezolizumab / tecentriq hybreza™️ for subcutaneous pd-l1 cancer immunotherapy in nsclc
-
21:35
agave-201 study - fda approval of axatilimab for chronic graft-versus-host disease (cgvhd)
-
21:19
estrogen receptors & her2/neu receptors in breast cancer (a tutorial from oster oncology)
-
1:33:20
clinical trials demystified: session 3. meet experts from the nctn, pharma & the fda
-
42:27
what you should know about fda project optimus for your oncology drug approval
-
3:33
breast cancer awareness month: the importance of mammograms
-
3:00
fda expands approval of breast cancer drug kisqali: what to know
-
1:34
dr. garcia on fda approval of pembrolizumab in bladder cancer
-
55:36
lmsdr webinar: fda oncology product development
-
35:06
oncology drug development in the era of precision medicine: fda perspective
-
4:13
tapur trial targets cancers with treatments outside of fda-approved indications
-
7:05
the fda approval of atezolizumab in bladder cancer
-
1:12
dr powell on the fda approval of dostarlimab plus chemo in advanced/recurrent endometrial cancer
-
0:28
ask a pharmacist: what medications are available to treat early breast cancer?
-
21:42
dr. hope rugo discusses capivasertib fda approval based on capitello-291 study
-
3:21
fda d.i.s.c.o.: intro by dr. richard pazdur
-
17:40
mountaineer study lead to the tucatinib/trastuzumab fda approval - in discussion w/ dr. bekaii-saab